Tokyo Tape
Sign in
← Medical Ikkou Group

Quarterly report · Q2

3353.TEDINET S100S0UE
Period2023-03-01 → 2023-08-31
Filed2023-10-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥17.5bn2023-03-01 → 2023-08-31Cons.Net sales
Revenue¥33.9bn2022-03-01 → 2023-02-28Cons.Net sales (5-year summary)
Revenue¥17.0bn2022-03-01 → 2022-08-31Cons.Net sales
Operating income¥603m2023-03-01 → 2023-08-31Cons.Operating income
Operating income¥466m2022-03-01 → 2022-08-31Cons.Operating income
Ordinary income¥697m2023-03-01 → 2023-08-31Cons.Ordinary income
Ordinary income¥1.2bn2022-03-01 → 2023-02-28Cons.Ordinary income loss (5-year summary)
Ordinary income¥598m2022-03-01 → 2022-08-31Cons.Ordinary income
Profit before tax¥776m2023-03-01 → 2023-08-31Cons.Income before income taxes
Profit before tax¥624m2022-03-01 → 2022-08-31Cons.Income before income taxes
Net income (owners)¥444m2023-03-01 → 2023-08-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥760m2022-03-01 → 2023-02-28Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥374m2022-03-01 → 2022-08-31Cons.Profit loss attributable to owners of parent
Net income¥469m2023-03-01 → 2023-08-31Cons.Profit loss
Net income¥386m2022-03-01 → 2022-08-31Cons.Profit loss
Total assets¥28.5bnat 2023-08-31Cons.Assets
Total assets¥27.5bnat 2023-02-28Cons.Assets
Total assets¥28.3bnat 2022-08-31Cons.Total assets (5-year summary)
Total liabilities¥15.4bnat 2023-08-31Cons.Liabilities
Total liabilities¥14.9bnat 2023-02-28Cons.Liabilities
Net assets / equity¥13.1bnat 2023-08-31Cons.Net assets
Net assets / equity¥12.6bnat 2023-02-28Cons.Net assets
Net assets / equity¥12.2bnat 2022-08-31Cons.Net assets (5-year summary)
Cash and deposits¥6.7bnat 2023-08-31Cons.Cash and deposits
Cash and deposits¥6.4bnat 2023-02-28Cons.Cash and deposits
Cash & equivalents¥6.5bnat 2023-08-31Cons.Cash and cash equivalents
Cash & equivalents¥6.3bnat 2023-02-28Cons.Cash and cash equivalents
Cash & equivalents¥6.8bnat 2022-08-31Cons.Cash and cash equivalents
Cash & equivalents¥7.8bnat 2022-02-28dCons.Cash and cash equivalents
Operating cash flow¥848m2023-03-01 → 2023-08-31Cons.Net cash provided by used in operating activities
Operating cash flow¥1.3bn2022-03-01 → 2023-02-28Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥496m2022-03-01 → 2022-08-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥338m2023-03-01 → 2023-08-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥478m2022-03-01 → 2023-02-28Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥291m2022-03-01 → 2022-08-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥217m2023-03-01 → 2023-08-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥2.4bn2022-03-01 → 2023-02-28Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥1.2bn2022-03-01 → 2022-08-31Cons.Net cash provided by used in financing activities
EPS (basic)¥118.262023-03-01 → 2023-08-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥61.842023-06-01 → 2023-08-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥202.22022-03-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥99.652022-03-01 → 2022-08-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥44.262022-06-01 → 2022-08-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio43.9%at 2023-08-31Cons.Equity to asset ratio (5-year summary)
Equity ratio43.8%at 2023-02-28Cons.Equity to asset ratio (5-year summary)
Equity ratio41.2%at 2022-08-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 44
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-03-01 → 2023-08-31−¥472m
Reconciling Itemsreconcilingrevenue intersegment2023-03-01 → 2023-08-31−¥472m
Reconciling Itemsreconcilingsegment profit2023-03-01 → 2023-08-31−¥387m
jpcrp040300-q2r_E03443-000Dispensing Pharmacyreportable segmentrevenue2023-03-01 → 2023-08-31¥11.9bn
jpcrp040300-q2r_E03443-000Dispensing Pharmacyreportable segmentrevenue external2023-03-01 → 2023-08-31¥11.9bn
jpcrp040300-q2r_E03443-000Dispensing Pharmacyreportable segmentsegment profit2023-03-01 → 2023-08-31¥780m
jpcrp040300-q2r_E03443-000Health Carereportable segmentrevenue2023-03-01 → 2023-08-31¥3.9bn
jpcrp040300-q2r_E03443-000Health Carereportable segmentrevenue external2023-03-01 → 2023-08-31¥3.9bn
jpcrp040300-q2r_E03443-000Health Carereportable segmentrevenue intersegment2023-03-01 → 2023-08-31¥300,000
jpcrp040300-q2r_E03443-000Health Carereportable segmentsegment profit2023-03-01 → 2023-08-31¥111m
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentrevenue2023-03-01 → 2023-08-31¥2.1bn
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentrevenue external2023-03-01 → 2023-08-31¥1.6bn
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentrevenue intersegment2023-03-01 → 2023-08-31¥470m
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentsegment profit2023-03-01 → 2023-08-31¥34m
jpcrp040300-q2r_E03443-000Real Estatereportable segmentrevenue2023-03-01 → 2023-08-31¥93m
jpcrp040300-q2r_E03443-000Real Estatereportable segmentrevenue external2023-03-01 → 2023-08-31¥91m
jpcrp040300-q2r_E03443-000Real Estatereportable segmentrevenue intersegment2023-03-01 → 2023-08-31¥2m
jpcrp040300-q2r_E03443-000Real Estatereportable segmentsegment profit2023-03-01 → 2023-08-31¥66m
Total Of Reportable Segments And Otherssegment totalrevenue2023-03-01 → 2023-08-31¥17.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-03-01 → 2023-08-31¥17.5bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-03-01 → 2023-08-31¥472m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-03-01 → 2023-08-31¥990m
Reconciling Itemsreconcilingrevenue2022-03-01 → 2022-08-31−¥497m
Reconciling Itemsreconcilingrevenue intersegment2022-03-01 → 2022-08-31−¥497m
Reconciling Itemsreconcilingsegment profit2022-03-01 → 2022-08-31−¥385m
jpcrp040300-q2r_E03443-000Dispensing Pharmacyreportable segmentrevenue2022-03-01 → 2022-08-31¥11.6bn
jpcrp040300-q2r_E03443-000Dispensing Pharmacyreportable segmentrevenue external2022-03-01 → 2022-08-31¥11.6bn
jpcrp040300-q2r_E03443-000Dispensing Pharmacyreportable segmentsegment profit2022-03-01 → 2022-08-31¥736m
jpcrp040300-q2r_E03443-000Health Carereportable segmentrevenue2022-03-01 → 2022-08-31¥3.9bn
jpcrp040300-q2r_E03443-000Health Carereportable segmentrevenue external2022-03-01 → 2022-08-31¥3.9bn
jpcrp040300-q2r_E03443-000Health Carereportable segmentrevenue intersegment2022-03-01 → 2022-08-31¥300,000
jpcrp040300-q2r_E03443-000Health Carereportable segmentsegment profit2022-03-01 → 2022-08-31¥35m
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentrevenue2022-03-01 → 2022-08-31¥1.9bn
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentrevenue external2022-03-01 → 2022-08-31¥1.4bn
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentrevenue intersegment2022-03-01 → 2022-08-31¥495m
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentsegment profit2022-03-01 → 2022-08-31¥20m
jpcrp040300-q2r_E03443-000Real Estatereportable segmentrevenue2022-03-01 → 2022-08-31¥95m
jpcrp040300-q2r_E03443-000Real Estatereportable segmentrevenue external2022-03-01 → 2022-08-31¥94m
jpcrp040300-q2r_E03443-000Real Estatereportable segmentrevenue intersegment2022-03-01 → 2022-08-31¥876,000
jpcrp040300-q2r_E03443-000Real Estatereportable segmentsegment profit2022-03-01 → 2022-08-31¥61m
Total Of Reportable Segments And Otherssegment totalrevenue2022-03-01 → 2022-08-31¥17.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-03-01 → 2022-08-31¥17.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-03-01 → 2022-08-31¥497m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-03-01 → 2022-08-31¥851m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 499
ItemContextValueUnit
Number of shares heldCurrentQuarterInstant_No1MajorShareholdersMember1020000
Shareholding ratioCurrentQuarterInstant_No1MajorShareholdersMember0.2714
Number of shares heldCurrentQuarterInstant_No2MajorShareholdersMember360000
Shareholding ratioCurrentQuarterInstant_No2MajorShareholdersMember0.0957
Number of shares heldCurrentQuarterInstant_No3MajorShareholdersMember242400
Shareholding ratioCurrentQuarterInstant_No3MajorShareholdersMember0.0645
Number of shares heldCurrentQuarterInstant_No4MajorShareholdersMember234200
Shareholding ratioCurrentQuarterInstant_No4MajorShareholdersMember0.0623
Number of shares heldCurrentQuarterInstant_No5MajorShareholdersMember234200
Shareholding ratioCurrentQuarterInstant_No5MajorShareholdersMember0.0623
Number of shares heldCurrentQuarterInstant_No6MajorShareholdersMember203000
Shareholding ratioCurrentQuarterInstant_No6MajorShareholdersMember0.0540
Number of shares heldCurrentQuarterInstant_No7MajorShareholdersMember143246
Shareholding ratioCurrentQuarterInstant_No7MajorShareholdersMember0.0381
Number of shares heldCurrentQuarterInstant_No8MajorShareholdersMember140000
Shareholding ratioCurrentQuarterInstant_No8MajorShareholdersMember0.0372
Number of shares heldCurrentQuarterInstant_No9MajorShareholdersMember120000
Shareholding ratioCurrentQuarterInstant_No9MajorShareholdersMember0.0319
Number of shares heldCurrentQuarterInstant_No10MajorShareholdersMember100000
Shareholding ratioCurrentQuarterInstant_No10MajorShareholdersMember0.0266
Number of shares heldCurrentQuarterInstant2797046
Shareholding ratioCurrentQuarterInstant0.7442
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember－
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember311800
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember3757200
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember37572
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember1000
Number of shares issued shares voting rightsCurrentQuarterInstant4070000
Number of voting rights issued shares voting rightsCurrentQuarterInstant37572
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member311800
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member－
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member311800
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0766
Number of shares held in own name treasury shares etcCurrentQuarterInstant311800
Number of shares held in others names treasury shares etcCurrentQuarterInstant－
Total number of shares held treasury shares etcCurrentQuarterInstant311800
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0766
Cash and depositsPrior1YearInstant6443169000JPY
Cash and depositsCurrentQuarterInstant6739978000JPY
Accounts receivable tradePrior1YearInstant5009077000JPY
Accounts receivable tradeCurrentQuarterInstant5438722000JPY
MerchandisePrior1YearInstant1228229000JPY
MerchandiseCurrentQuarterInstant1298617000JPY
Other caPrior1YearInstant561431000JPY
Other caCurrentQuarterInstant507927000JPY
Allowance for doubtful accounts caPrior1YearInstant-2388000JPY
Allowance for doubtful accounts caCurrentQuarterInstant-2388000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-02-28pass
balance sheet identityconsolidated 2023-08-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-02-28pass
statement vs summary · net assetsconsolidated 2023-08-31pass
statement vs summary · net income attributable to parentconsolidated 2022-03-01/2022-08-31pass
statement vs summary · net income attributable to parentconsolidated 2023-03-01/2023-08-31pass
statement vs summary · operating cash flowconsolidated 2022-03-01/2022-08-31pass
statement vs summary · operating cash flowconsolidated 2023-03-01/2023-08-31pass
statement vs summary · revenueconsolidated 2022-03-01/2022-08-31pass
statement vs summary · revenueconsolidated 2023-03-01/2023-08-31pass
statement vs summary · total assetsconsolidated 2023-02-28pass
statement vs summary · total assetsconsolidated 2023-08-31pass